No description available.

Modular domains of proteins are important in cellular signaling processes. Eukaryotic cells are constantly undergoing DNA damage due to exogenous and endogenous sources of damage. The DNA damage response (DDR) involves a complex network of signaling events mediated by modular domains such as the BRCT (BRCA1 C-terminal) domains. Therefore, proteins containing BRCT domains are important for DNA damage detection and signaling. In this dissertation, we focus on two BRCT-containing proteins BRCA1 and PAXIP1. BRCA1 is a gene that is known to be associated with increased risk of hereditary breast and ovarian cancer. Germline variants of BRCA1 are assessed to determine lifetime risk of developing breast and ovarian cancer. This is performed by genetic testing of the BRCA1 sequence and the variants can be classified as pathogenic, non-pathogenic or variants of unknown significance (VUS). Using family history, segregation analysis, co-occurrence and tumor pathology, certain variants have been classified as either pathogenic or non-pathogenic. However, a large majority of the variants are classified as VUS. Functional assays are critical in providing insight in the case of VUS results. We have a developed a visualization resource to aid in functional analysis of BRCA1 missense variants that occur due to single amino acid changes. This tool is known as BRCA1 Circos (http://research.nhgri.nih.gov/bic/circos/) and it aggregates, harmonizes and allows interpretation of data from all published studies on functional analysis of BRCA1 missense variants. Therefore, this is an important tool that will aid in the meta-analysis of functional data needed to better assess VUS. Functional studies of BRCA1 also demonstrate that majority of the variants that have a functional impact on the protein lie in the BRCT region of the protein. This indicates that the BRCT region is important in cancer development. To further analyze the function of BRCT-containing proteins, a study was previously undertaken to evaluate the role of BRCT-containing proteins and their interaction partners in the DNA damage response and consequently, cancer. BRCT domains of seven BRCT-containing proteins were used as baits and their binding partners were demonstrated to be highly enriched in the DDR process. We hypothesized that members of this BRCT-centric protein-protein interaction network could constitute targets for sensitization to DNA damaging chemotherapy agents in lung cancer. Therefore, we probed this established dataset containing the protein-protein interaction network (PPIN) of seven BRCT-containing proteins to identify seventeen kinases. A systematic pharmacological screen was performed to evaluate these kinases as targets to enhance platinum-based chemotherapy in lung cancer and this revealed WEE1, a mitotic kinase, as a potential target. Of the seventeen kinases, inhibition of mitotic kinase, WEE1, was found to have the most effective response in combination with platinum-based compounds in lung cancer cell lines. In the PPIN, WEE1 was shown to interact with PAXIP1 (PTIP), a BRCT-containing protein involved in transcription and in the cellular response to DNA damage. PAXIP1 has been shown to bind DDR proteins, such as 53BP1 and γH2AX, and also shown to be an important part of immune development. In this dissertation, we observe that WEE1 binds to PAXIP1 and PAXIP1 regulates the WEE1-mediated phosphorylation of its main substrate, CDK1. We also demonstrate that ectopic expression of PAXIP1 combined with WEE1 inhibitor, AZD1775, leads to an increase in the mitotic index at the G2/M checkpoint. Overexpression of PAXIP1 combined with AZD1775 treatment in cells with prior DNA damage causes high levels of caspase-3 mediated apoptosis as compared to AZD1775 treatment alone. In summary, we identify the role of PAXIP1 in sensitizing lung cancer cells to the WEE1 inhibitor, AZD1775, in combination with platinum-based therapy and propose the use of WEE1 and PAXIP1 levels as mechanism-based biomarkers. Overall, these studies indicate that BRCT-containing proteins through their role in the DDR and the cell cycle are crucial for both cancer prevention and therapy.

No description available.

Indiana University-Purdue University Indianapolis (IUPUI) / The anti-apoptotic protein Survivin and the cyclin-dependent kinase p34Cdc2 are involved in cell cycle progression and apoptosis. Activation of Cdc2 is required for its pro-apoptotic activity, which can be inhibited by phosphorylation at Tyrosine-15 (Tyr15). In transduced IL-3-dependent murine BaF3 hematopoietic cells, over-expression of wild-type-(wt)-Survivin increased Cdc2-Tyr15 phosphorylation, while over-expression of a dominant-negative-(dn)-T34A-Survivin construct decreased its phosphorylation. The increased phospho-Tyr15 levels associated with ectopic Survivin directly correlated with enhanced BaF3 cell survival in the absence of growth factors, and low phospho-Tyr15 levels observed in cells expressing ectopic dn-Survivin correlated with decreased survival. BaF3 cells transduced with Internal Tandem Duplication (ITD) mutations of the Flt3 receptor that results in increased Survivin levels, also contained increased levels of Tyr15 phosphorylated Cdc2. In BaF3 cells over-expressing wt-Survivin, 2-fold higher levels of Wee1 protein were observed compared to cells expressing control vector alone. Treatment of control BaF3 cells with the caspase-3 inhibitor Ac-DEVD-CHO increased both Cdc2-Tyr15 phosphorylation and Wee1 protein levels. In a similar fashion over-expression of wt-Survivin in these cells maintained high levels of Tyr15 phosphorylated Cdc2 and Wee1 protein. In MCF7 human breast cancer cells that lack caspase-3, increase of Tyr15 phosphorylated Cdc2 and Wee1 kinase protein by caspase-3, -7 or a pan-caspase inhibitor was absent, linking Survivin and caspase-3 to the increase of Wee1 and Tyr15 phosphorylation of Cdc2. To further link Survivin and Cdc2, we treated cells with AICAR and 17-AAG that inhibit Hsp90, which is known to be required for Survivin stability. Treatment of BaF3 cells expressing wt-Survivin with AICAR and 17-AAG decreased Cdc2-Tyr15 phosphorylation compared to vehicle-treated control cells. Taken together, these results indicate that Survivin protects the Cdc2-Tyr15-targeting kinase Wee1 from degradation by caspase-3 which leads to increased inhibitory Cdc2-Tyr15 phosphorylation resulting in reduced apoptosis and enhanced survival.

京都大学 / 新制・論文博士 / 博士(生命科学) / 乙第13626号 / 論生博第30号 / 新制||生||70(附属図書館) / 京都大学大学院生命科学研究科統合生命科学専攻 / (主査)教授 松本 智裕, 教授 河内 孝之, 教授 上村 匡 / 学位規則第4条第2項該当 / Doctor of Agricultural Science / Kyoto University / DFAM

京都大学 / 新制・課程博士 / 博士(医学) / 甲第25487号 / 医博第5087号 / 新制||医||1073(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 小濱 和貴, 教授 妹尾 浩, 教授 寺田 智祐 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

Le but de ces travaux de thèse est d’apporter une meilleure compréhension des mécanismes de régulation contrôlant la division cellulaire au niveau moléculaire. La division cellulaire est composée de la mitose et la cytocinèse. Les deux processus doivent être coordonnés étroitement afin de garantir la stabilité du génome. La division cellulaire doit aussi s’équilibrer avec la croissance cellulaire pour que les cellules conservent une taille constante au cours des cycles successifs. La levure S. pombe est un organisme modèle simple très utilisé pour des études de cycle cellulaire et de cytocinèse. Dans ce modèle, nous avons focalisé ce travail de thèse sur les nœuds corticaux médians, des structures protéiques complexes, qui ont une fonction double dans l’engagement en mitose et dans le positionnement du plan de division. Les nœuds médians corticaux sont organisés par la kinase SAD Cdr2. Leur localisation et leur fonction sont régulées négativement pour la DYRK kinase Pom1 qui forme des gradients émanant des extrémités de la cellule. Les nœuds corticaux médians contiennent une voie d’inhibition pour Wee1 qui promeut l’entrée en mitose. Cette voie implique la kinase SAD Cdr1, un inhibiteur direct de Wee1 et pourrait coupler l’entrée en mitose à la taille de la cellule par levée progressive de l’inhibition exercée par Pom1 quand les cellules s’allongent. Cdr2 recrute aussi l’anillin Mid1 sur les nœuds corticaux médians ainsi qu’une série de composants additionnels, Blt1, Gef2, Nod1 et Klp8, pour former des précurseurs médians de l’anneau contractile de cytocinèse qui se compactent en un anneau fin pendant la mitose. La localisation médiane des nœuds, contrôlée négativement par les gradients polaires de Pom1 prédéfinit ainsi le plan de division au centre géométrique de la cellule. Dans la première partie de ma thèse, j’ai étudié la protéine des nœuds corticaux médians Blt1 dont la fonction restait énigmatique. Nous avons montré que Blt1 promeut une association robuste de Mid1 avec les nœuds corticaux. Blt1 interagit avec Mid1 via le RhoGEF Gef2 pour stabiliser les nœuds au cortex cellulaire durant les premiers stades de l’assemblage de l’anneau contractile. L’extrémité N-terminale de Blt1 est nécessaire à sa localisation ainsi qu’à sa fonction, tandis que son extrémité C-terminale favorise sa localisation au cortex en interagissant avec des phospholipides. Dans des cellules dans lesquelles ni Mid1 ni Blt1 ne peuvent s’attacher à la membrane, les nœuds se détachent du cortex et génèrent des anneaux contractiles de cytocinèse aberrants. Nous en avons conclu que Blt1 agit comme une protéine d’échafaudage pour les précurseurs de l’anneau contractile, et que Blt1 et Mid1 constituent des ancres membranaires redondantes pour le positionnement du plan de division. Dans une deuxième partie de ma thèse, j’ai étudié comment Cdr2 organise les différents composants des nœuds en voies fonctionnelles qui favorisent l’entrée en mitose et la division médiane. J’ai montré que l’interaction de Cdr2 avec Wee1 et Mid1 dépend du domaine UBA de Cdr2 de manière dépendante de l’activité kinase. En revanche, Cdr1 s’associe avec l’extrémité C-terminale de Cdr2, composée des domaines basique et KA1 d’association aux lipides membranaires. De manière intéressante, Mid1 interagit également avec l’extrémité C-terminale de Cdr2 et pourrait ponter les parties N- et C-terminales de Cdr2, alors que Blt1 s’associe à la région centrale de Cdr2. Nous faisons l’hypothèse que l’association des effecteurs de Cdr2 avec différents domaines de Cdr2 pourraient contraindre Cdr1 et Wee1 spatialement pour promouvoir l'inhibition de Wee1 quand la kinase Cdr2 est active. / The aim of this PhD work is to bring a better understanding of the regulatory mechanism controlling cell division in space and time at the molecular level. Cell division is composed of mitosis and cytokinesis. Both processes need to be perfectly coordinated in order to guarantee genome integrity. Cell division also needs to be properly balanced with cell growth to maintain cell size constant during successive cell cycles. Temporal and spatial regulatory mechanisms ensure the coordination of these events. The fission yeast Schizosaccharomyces pombe is a simple rod-shaped model organism well-known for cell cycle and cytokinesis studies. In this model, we focused the work of this thesis on the medial cortical nodes, complexe protein structures that have a dual role in mitotic commitment and in division plane positioning. Medial cortical nodes are organized by the SAD kinase Cdr2. Their localization and function is negatively regulated by the DYRK kinase Pom1 that forms a gradient emanating from the cell tips. Medial cortical nodes contain an inhibitory pathway for Wee1, promoting mitotic entry. This pathway involves the SAD kinase Cdr1, a direct inhibitor of Wee1 and has been proposed to couple mitotic entry to cell size by progressive alleviation of Pom1 inhibition when cells grow longer. Cdr2 also recruits to medial nodes the anillin Mid1 as well as a series of four additional components, Blt1, Gef2, Nod1 and Klp8, to form medial precursors for the cytokinetic contractile ring that compact into a tight ring during mitosis. Nodes medial localization, negatively controlled by Pom1 gradients, predefines thereby the division plane in the cell geometrical center. In a first part of my thesis, I studied the previously enigmatic cortical node protein Blt1. We showed that Blt1 promotes the robust association of Mid1 with cortical nodes. Blt1 interacts with Mid1 through the RhoGEF Gef2 to stabilize nodes at the cell cortex during the early stages of contractile ring assembly. The Blt1 N terminus is required for localization and function, while the Blt1 C terminus promotes cortical localization by interacting with phospholipids. In cells lacking membrane binding by both Mid1 and Blt1, nodes detach from the cell cortex and generate aberrant cytokinetic rings. We conclude that Blt1 acts as a scaffolding protein for precursors of the cytokinetic ring and that Blt1 and Mid1 provide overlapping membrane anchors for proper division plane positioning. In the second part of my thesis, I studied how Cdr2 scaffolds various nodes components to organize them in functional pathways promoting mitotic commitment and medial division. I showed that Cdr2 interaction with Wee1 and Mid1, depends on Cdr2 UBA domain in a kinase activity dependent manner. In contrast, Cdr1 associates with Cdr2 C-terminus composed of basic and KA-1 lipid-binding domains. Interestingly, Mid1 also interacts with Cdr2 C-terminus and may the bridge N- and C-terminal domains of Cdr2 while Blt1 associates with the central spacer region. We propose that the association of Cdr2 effectors with different Cdr2 domains may constrain Cdr1 and Wee1 spatially to promote Wee1 inhibition upon Cdr2 kinase activation.

DNA is wrapped around proteins called histones, whose modification regulates numerous cellular processes. Therefore it is not surprising that mutations in the genes that modify the histones are frequently associated with human cancer. For example, mutations in SETD2, encoding the sole enzyme that catalyses histone H3 lysine 36 trimethylation (H3K36me3), occur frequently in multiple cancer types. This identifies H3K36me3 loss as an important event in cancer development, and also as a potential therapeutic target. This thesis investigates the following questions: (1) how does the loss of H3K36me3 contribute to cancer development; and (2) what therapy can be used to kill cancers that have already lost H3K36me3. To answer the first question, this thesis shows that H3K36me3 facilitates the accurate repair of DNA double-stranded breaks (DSBs) by homologous recombination (HR). H3K36me3 promotes HR by recruiting CtIP to the site of DSBs to carry out resection, allowing the binding of HR proteins (such as RPA and RAD51) to the damage sites. Thus it is proposed that error-free HR repair within H3K36me3-decorated transcriptionally active genomic regions suppresses genetic mutations which could promote tumourigenesis. To answer the second question, this thesis reveals a clinically relevant synthetic lethal interaction between H3K36me3 loss and WEE1 inhibition. WEE1 inhibition selectively kills H3K36me3-deficient cells by inhibiting DNA replication, and subsequent fork stalling results in MUS81 endonuclease-dependent DNA damage and cell death. The mechanism is found to be synergistic depletion of RRM2 (ribonucleotide reductase small subunit), the enzyme that generates deoxyribonucleotides (dNTPs). This work reveals two pathways that regulate RRM2: one involves transcriptional activation of RRM2 by H3K36me3, and the other involves RRM2 degradation regulated by Cyclin-Dependent Kinase, CDK1 (which is controlled by WEE1, CHK1 and ATR). Based on this mechanism, the synthetic lethal interaction is expanded, from between two genes, to between two pathways. Supported by in vivo experiments, the study suggests that patients with cancers that have lost H3K36me3 could benefit from treatment with the inhibitors of WEE1, CHK1 or ATR.